cyclosporine has been researched along with Anal Fistula in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 8 (53.33) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Harvey, R; Horton, H | 1 |
Falk, EB; Ferrer, L; Hoffman, A; Juopperi, T; Kimbrel, EA; Lam, A; Lanza, R; Zewe, C | 1 |
Hardie, RJ; McAnulty, JE; Patricelli, AJ | 1 |
Guaguère, E; Olivry, T; Steffan, J | 1 |
Gregory, SP; Guitian, J; Hardie, RJ; House, AK | 1 |
Koutroubakis, IE | 1 |
Guardiola, J; Rodríguez-Moranta, F; Soriano-Izquierdo, A | 1 |
Lichtiger, S; Present, DH | 1 |
Hanauer, SB; Smith, MB | 1 |
Aichbichler, B; Fickert, P; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Ranner, G | 1 |
Mathews, KA; Sukhiani, HR | 1 |
Beluffi, G; Caselli, D; Maccabruni, A; Minoli, L | 1 |
Barabino, A; Biscaldi, E; Castellano, E; Gandullia, P | 1 |
Paré, P | 1 |
Mouatt, JG | 1 |
3 review(s) available for cyclosporine and Anal Fistula
Article | Year |
---|---|
Cyclosporin A: a new drug in the field of canine dermatology.
Topics: Administration, Oral; Animals; Cyclosporine; Dermatitis, Atopic; Dog Diseases; Dogs; Humans; Infusions, Intravenous; Randomized Controlled Trials as Topic; Rectal Fistula | 2004 |
[Current status of treatment of inflammatory bowel disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Infusions, Intravenous; Mercaptopurine; Meta-Analysis as Topic; Polyethylene Glycols; Quality of Life; Rectal Fistula; Recurrence; Time Factors | 2007 |
Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide | 2001 |
4 trial(s) available for cyclosporine and Anal Fistula
Article | Year |
---|---|
Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Male; Perianal Glands; Rectal Fistula; Recurrence; Treatment Outcome | 2002 |
Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Female; Immunosuppressive Agents; Male; Perianal Glands; Preoperative Care; Prospective Studies; Rectal Fistula; Severity of Illness Index; Treatment Outcome | 2006 |
Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs.
Topics: Animals; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Immunosuppressive Agents; Male; Perianal Glands; Rectal Fistula; Time Factors; Treatment Outcome | 1997 |
Cyclosporin and ketoconazole interaction for treatment of perianal fistulas in the dog.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Male; Perianal Glands; Prospective Studies; Rectal Fistula; Treatment Outcome | 2002 |
8 other study(ies) available for cyclosporine and Anal Fistula
Article | Year |
---|---|
Successful treatment of perianal fistulas in two dogs with oclacitinib.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Pyrimidines; Rectal Fistula | 2023 |
Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn's disease.
Topics: Animals; Crohn Disease; Cyclosporine; Cytokines; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Follow-Up Studies; Heterografts; Human Embryonic Stem Cells; Humans; Immunomodulation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rectal Fistula; Stromal Cells | 2016 |
The patient with persistent perianal fistulae.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Infliximab; Magnetic Resonance Imaging; Mercaptopurine; Rectal Fistula; Tacrolimus; Treatment Outcome | 2007 |
Efficacy of cyclosporine in treatment of fistula of Crohn's disease.
Topics: Adult; Crohn Disease; Cutaneous Fistula; Cyclosporine; Female; Humans; Male; Middle Aged; Pilot Projects; Rectal Fistula; Rectovaginal Fistula | 1994 |
Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
Topics: Administration, Oral; Adult; Crohn Disease; Cyclosporine; Female; Humans; Infusions, Intravenous; Intestinal Fistula; Middle Aged; Rectal Fistula; Recurrence; Time Factors; Vaginal Fistula | 1993 |
Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Prednisolone; Rectal Fistula; Rectum; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
Cyclosporine for rectoperineal fistula in a human immunodeficiency virus-infected child.
Topics: Adolescent; Antiviral Agents; Burkitt Lymphoma; Child; Cyclosporine; Fistula; HIV Infections; Humans; Male; Perineum; Rectal Fistula | 1999 |
A girl with severe fistulizing Crohn's disease.
Topics: Brain Diseases; Child; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Magnetic Resonance Imaging; Rectal Fistula; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2000 |